Perspectives on geriatric pharmacotherapy
- PMID: 1862013
Perspectives on geriatric pharmacotherapy
Abstract
In the United States the population over 85 years of age use a disproportionately large percentage of health care resources, including drugs. The elderly take approximately one-third of all medications. Among other factors, the need for several agents predisposes them to adverse drug reactions and drug interactions. Sequelae from drug usage in the elderly are more common than in younger patient populations, and often result in hospitalization. Careful patient monitoring is imperative for optimum pharmacotherapy in elderly patients.
Similar articles
-
Drug combinations and potential for risk of adverse drug reaction among community-dwelling elderly.Nurs Res. 1994 Jan-Feb;43(1):44-9. Nurs Res. 1994. PMID: 8295840
-
Adverse drug effects.Clin Geriatr Med. 1990 May;6(2):293-307. Clin Geriatr Med. 1990. PMID: 2184925 Review.
-
Polypharmacy in older oncology patients and the need for an interdisciplinary approach to side-effect management.J Clin Pharm Ther. 2007 Apr;32(2):169-75. doi: 10.1111/j.1365-2710.2007.00815.x. J Clin Pharm Ther. 2007. PMID: 17381667
-
Rational drug therapy in the elderly or how not to poison your elderly patients.Aust Fam Physician. 1992 Dec;21(12):1755-60. Aust Fam Physician. 1992. PMID: 1476504 Review.
-
Polypharmacy and perioperative medications in the elderly.Anesthesiol Clin. 2009 Sep;27(3):377-89, table of contents. doi: 10.1016/j.anclin.2009.07.004. Anesthesiol Clin. 2009. PMID: 19825482 Review.
Cited by
-
The epidemiology of serious adverse drug reactions among the elderly.Drugs Aging. 1999 Feb;14(2):141-52. doi: 10.2165/00002512-199914020-00005. Drugs Aging. 1999. PMID: 10084366 Review.
-
Pharmacokinetic and pharmacodynamic changes in the elderly. Clinical implications.Clin Pharmacokinet. 1998 Jul;35(1):49-64. doi: 10.2165/00003088-199835010-00004. Clin Pharmacokinet. 1998. PMID: 9673834 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources